Responses
Novel treatment (new drug/intervention; established drug/procedure in new situation)
CASE REPORT
Brentuximab vedotin in combination with sequential procarbazine, cyclophosphamide and prednisolone for the management of Hodgkin’s lymphoma-associated vanishing bile duct syndrome (VBDS) with severe obstructive liver failure
Compose a Response to This Article
Other responses
No responses have been published for this article.